Phase 2 Randomized Study of Radiation Therapy and 3-Year Androgen Deprivation With or Without Concurrent Weekly Docetaxel in High-Risk Localized Prostate Cancer Patients

Joan Carles; Enrique Gallardo; Montserrat Doménech; Albert Font; Joaquim Bellmunt; Mariona Figols; Begoña Mellado; María Isabel Sáez; Cristina Suárez; María José Méndez; Pablo Maroto; Raquel Luque; Teresa de Portugal; Ramón Aldabo; Teresa Bonfill; Rafael Morales-Barrera; José García; Sonia Maciá; Xavier Maldonado; Palmira Foro

doi:10.1016/j.ijrobp.2018.10.005

Phase 2 Randomized Study of Radiation Therapy and 3-Year Androgen Deprivation With or Without Concurrent Weekly Docetaxel in High-Risk Localized Prostate Cancer Patients

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2018.10.005 ◽

2019 ◽

Vol 103 (2) ◽

pp. 344-352 ◽

Cited By ~ 2

Author(s):

Joan Carles ◽

Enrique Gallardo ◽

Montserrat Doménech ◽

Albert Font ◽

Joaquim Bellmunt ◽

...

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

High Risk ◽

Cancer Patients ◽

Randomized Study ◽

Androgen Deprivation ◽

Localized Prostate Cancer ◽

Phase 2 ◽

Weekly Docetaxel

Download Full-text

The Prognostic Value of Expression of HIF1α, PAK-6, and PSMB4 in Intermediate- and High-Risk Localized Prostate Cancer Patients Treated With Androgen Deprivation and Dose Escalation Radiation Therapy

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2013.06.1755 ◽

2013 ◽

Vol 87 (2) ◽

pp. S662-S663

Author(s):

A. Zapatero ◽

M. Morente ◽

C. Martin de Vidales ◽

C. Lopez ◽

M. Adrados ◽

...

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

High Risk ◽

Cancer Patients ◽

Dose Escalation ◽

Prognostic Value ◽

Androgen Deprivation ◽

Localized Prostate Cancer

Download Full-text

34 Phase 2 study of neoadjuvant docetaxel and androgen suppression (AS) Plus Radiation Therapy (RT) for high risk localized prostate cancer (HRLCaP)

Radiotherapy and Oncology ◽

10.1016/s0167-8140(06)80775-9 ◽

2006 ◽

Vol 80 ◽

pp. S10-S11

Author(s):

M. McKenzie ◽

K. Chi ◽

A. Neville ◽

S. Ellard ◽

B. Baerg ◽

...

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

High Risk ◽

Localized Prostate Cancer ◽

Phase 2 ◽

Phase 2 Study ◽

Androgen Suppression

Download Full-text

Multicenter phase 2 study of neoadjuvant paclitaxel, estramustine phosphate, and carboplatin plus androgen deprivation before radiation therapy in patients with unfavorable-risk localized prostate cancer

Cancer ◽

10.1002/cncr.23910 ◽

2008 ◽

Vol 113 (11) ◽

pp. 3137-3145 ◽

Cited By ~ 10

Author(s):

William Kevin Kelly ◽

Susan Halabi ◽

Aymen Elfiky ◽

San-San Ou ◽

Jeff Bogart ◽

...

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

Androgen Deprivation ◽

Localized Prostate Cancer ◽

Phase 2 ◽

Estramustine Phosphate ◽

Multicenter Phase ◽

Phase 2 Study

Download Full-text

POD-01.06: Phase II trial of weekly docetaxel and complete androgen blockade prior to radical prostatectomy in high-risk localized prostate cancer patients

Urology ◽

10.1016/j.urology.2007.06.011 ◽

2007 ◽

Vol 70 (3) ◽

pp. 2-3

Author(s):

F.J. Gómez Veiga ◽

A. Sousa ◽

A. Alcaraz ◽

J. Areal ◽

N. Hannaoui ◽

...

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Radical Prostatectomy ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Trial ◽

Localized Prostate Cancer ◽

Weekly Docetaxel ◽

Complete Androgen Blockade ◽

Androgen Blockade

Download Full-text

The prognostic value of expression of HIF1α, EGFR and VEGF-A, in localized prostate cancer for intermediate- and high-risk patients treated with radiation therapy with or without androgen deprivation therapy

Radiation Oncology ◽

10.1186/1748-717x-7-66 ◽

2012 ◽

Vol 7 (1) ◽

Cited By ~ 26

Author(s):

Damien C Weber ◽

Jean-Christophe Tille ◽

Christophe Combescure ◽

Jean-François Egger ◽

Mahomet Laouiti ◽

...

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

High Risk ◽

Androgen Deprivation Therapy ◽

Prognostic Value ◽

Androgen Deprivation ◽

Localized Prostate Cancer ◽

High Risk Patients ◽

Risk Patients

Download Full-text

Three Dimensional Telomeric Profiles in Circulating Tumor Cells of High-Risk Prostate Cancer Patients Undergoing Androgen Deprivation and Radiation Therapy

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2015.07.249 ◽

2015 ◽

Vol 93 (3) ◽

pp. S103-S104

Author(s):

L. Wark ◽

H.C. Quon ◽

A. Ong ◽

S. Ahmed ◽

R. Koul ◽

...

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

High Risk ◽

Cancer Patients ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Three Dimensional ◽

Androgen Deprivation ◽

High Risk Prostate Cancer ◽

Risk Prostate Cancer

Download Full-text

Nadir PSA is a strong predictor of treatment outcome in intermediate and high risk localized prostate cancer patients treated by definitive external beam radiotherapy and androgen deprivation

Radiation Oncology ◽

10.1186/s13014-017-0884-y ◽

2017 ◽

Vol 12 (1) ◽

Cited By ~ 7

Author(s):

Fady B. Geara ◽

Muhammad Bulbul ◽

Raja B. Khauli ◽

Therese Y. Andraos ◽

Mirna Abboud ◽

...

Keyword(s):

Prostate Cancer ◽

Treatment Outcome ◽

High Risk ◽

Cancer Patients ◽

Strong Predictor ◽

External Beam Radiotherapy ◽

Androgen Deprivation ◽

Localized Prostate Cancer ◽

External Beam

Download Full-text

Continued Benefit to Androgen Deprivation Therapy for Prostate Cancer Patients Treated With Dose-Escalated Radiation Therapy Across Multiple Definitions of High-Risk Disease

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2011.04.037 ◽

2011 ◽

Vol 81 (4) ◽

pp. e335-e344 ◽

Cited By ~ 27

Author(s):

Matthew H. Stenmark ◽

Kevin Blas ◽

Schuyler Halverson ◽

Howard M. Sandler ◽

Felix Y. Feng ◽

...

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

High Risk ◽

Cancer Patients ◽

Androgen Deprivation Therapy ◽

Androgen Deprivation ◽

High Risk Disease

Download Full-text

Biochemical Relapse-Free Survival After High Dose External Radiotherapy (≥78Gy) and 6 Months of Androgen Deprivation in High-Risk Localized Prostate Cancer Patients

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2005.07.494 ◽

2005 ◽

Vol 63 ◽

pp. S289-S290

Author(s):

A. Reuther ◽

C. Reddy ◽

A. Mahadevan ◽

P. Kupelian

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Cancer Patients ◽

Androgen Deprivation ◽

Localized Prostate Cancer ◽

High Dose ◽

External Radiotherapy ◽

Biochemical Relapse ◽

Relapse Free Survival ◽

Free Survival

Download Full-text

Adjuvant androgen-deprivation therapy following prostate total cryoablation in high-risk localized prostate cancer patients — Open-labeled randomized clinical trial

Cryobiology ◽

10.1016/j.cryobiol.2018.04.003 ◽

2018 ◽

Vol 82 ◽

pp. 88-92 ◽

Cited By ~ 1

Author(s):

Chung-Hsin Chen ◽

Yeong-Shiau Pu

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

High Risk ◽

Randomized Clinical Trial ◽

Cancer Patients ◽

Androgen Deprivation Therapy ◽

Androgen Deprivation ◽

Localized Prostate Cancer

Download Full-text